|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/136 | |
| A61K 31/145 | |||
| A61K 31/167 | |||
| A61P 9/00 | |||
| A61P 9/10 | |||
| A61P 17/02 | |||
| A61P 13/12 | |||
| A61P 17/14 | |||
| A61P 15/10 |
| (11) | Number of the document | 3011957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15185378.5 |
| Date of filing the European patent application | 2015-09-16 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 20140143603 | 2014-10-22 | KR |
| (72) |
Koh, Youngjun, KR
Park, Sangchul, KR
Cho, Sungchun, KR
Jo, Hongseok, KR
|
| (73) |
Samsung Electronics Co., Ltd.,
129, Samsung-ro Yeongtong-gu Suwon-si, Gyeonggi-do 443-742,
KR
|
| (54) | COMPOSITION FOR STIMULATING NEOVASCULARIZATION AT A SITE IN A SUBJECT COMPRISING DAPSONE AND USE THEREOF |
| COMPOSITION FOR STIMULATING NEOVASCULARIZATION AT A SITE IN A SUBJECT COMPRISING DAPSONE AND USE THEREOF |